| Dr Lois M Townshend, MD | |
|
45 Resnik Rd, Suite 301, Plymouth, MA 02360-4844 | |
| (508) 747-4748 | |
| (508) 747-0124 |
| Full Name | Dr Lois M Townshend |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 39 Years |
| Location | 45 Resnik Rd, Plymouth, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356450456 | NPI | - | NPPES |
| 3065987 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 073096 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Eye Surgeons | 7012982432 | 4 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from preclinical studies of its proprietary vaccine thermostabilization technology indicating that Soligenix is able to produce stable vaccine formulations using adjuvants, protein immunogens, and other components that ordinarily would not withstand long temperature variations exceeding customary refrigerated storage conditions.
Amorfix Life Sciences and Epitomics, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS(TM) computational platform discovery technology, which will be used by Epitomics to generate highly specific monoclonal antibodies (mAbs).
University of Cincinnati (UC) researchers have discovered that altered islet cell function and reduced insulin clearance contribute to excessive post-meal insulin response in patients experiencing low blood sugar symptoms (hypoglycemia) following gastric bypass surgery.
A new study, published on the bioRxiv* preprint server, hypothesized that ACE-2 expression and ADAM17 activity in the placenta is affected by the timing of SARS-CoV-2 infection of the mother.
Researchers at the University of Pennsylvania School of Medicine have determined that a well-known chemical process called acetylation has a previously unrecognized association with one of the biological processes associated with Alzheimer's disease and related disorders. The findings were published in the latest issue of Nature Communications.
› Verified 7 days ago
| Entity Name | Associated Eye Surgeons |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659338770 PECOS PAC ID: 7012982432 Enrollment ID: O20040921000542 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from preclinical studies of its proprietary vaccine thermostabilization technology indicating that Soligenix is able to produce stable vaccine formulations using adjuvants, protein immunogens, and other components that ordinarily would not withstand long temperature variations exceeding customary refrigerated storage conditions.
Amorfix Life Sciences and Epitomics, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS(TM) computational platform discovery technology, which will be used by Epitomics to generate highly specific monoclonal antibodies (mAbs).
University of Cincinnati (UC) researchers have discovered that altered islet cell function and reduced insulin clearance contribute to excessive post-meal insulin response in patients experiencing low blood sugar symptoms (hypoglycemia) following gastric bypass surgery.
A new study, published on the bioRxiv* preprint server, hypothesized that ACE-2 expression and ADAM17 activity in the placenta is affected by the timing of SARS-CoV-2 infection of the mother.
Researchers at the University of Pennsylvania School of Medicine have determined that a well-known chemical process called acetylation has a previously unrecognized association with one of the biological processes associated with Alzheimer's disease and related disorders. The findings were published in the latest issue of Nature Communications.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lois M Townshend, MD 45 Resnik Rd, Suite 301, Plymouth, MA 02360-4844 Ph: (508) 747-4748 | Dr Lois M Townshend, MD 45 Resnik Rd, Suite 301, Plymouth, MA 02360-4844 Ph: (508) 747-4748 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from preclinical studies of its proprietary vaccine thermostabilization technology indicating that Soligenix is able to produce stable vaccine formulations using adjuvants, protein immunogens, and other components that ordinarily would not withstand long temperature variations exceeding customary refrigerated storage conditions.
Amorfix Life Sciences and Epitomics, Inc. announced today that they have entered into an agreement to develop high-affinity monoclonal antibodies against a number of targets for cancer. Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS(TM) computational platform discovery technology, which will be used by Epitomics to generate highly specific monoclonal antibodies (mAbs).
University of Cincinnati (UC) researchers have discovered that altered islet cell function and reduced insulin clearance contribute to excessive post-meal insulin response in patients experiencing low blood sugar symptoms (hypoglycemia) following gastric bypass surgery.
A new study, published on the bioRxiv* preprint server, hypothesized that ACE-2 expression and ADAM17 activity in the placenta is affected by the timing of SARS-CoV-2 infection of the mother.
Researchers at the University of Pennsylvania School of Medicine have determined that a well-known chemical process called acetylation has a previously unrecognized association with one of the biological processes associated with Alzheimer's disease and related disorders. The findings were published in the latest issue of Nature Communications.
› Verified 7 days ago
Eddie F Kadrmas, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-746-8600 Fax: 508-747-1002 | |
Daniel J O'connor, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 146 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-833-6000 Fax: 508-534-6060 | |
Shazia Saman Ahmed, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-746-6178 | |
Dr. Henry J Kriegstein, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 45 Resnik Rd, Suite 301, Plymouth, MA 02360 Phone: 508-747-4748 Fax: 508-747-0124 | |
Allan W. Berg, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 40 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-746-8600 Fax: 508-747-1002 | |
Charles T. Post Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 40 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-746-8600 Fax: 508-747-1002 |